Aztreonam
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Data from a single case report (Int J Antimicrob Agents 2026;67:107692). |
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Data from a single case report (Int J Antimicrob Agents 2026;67:107692). |